pitavastatin

Known as: Pitavastatia, (3R,5S,6E)-7-[2-Cyclopropyl-4-(P-Fluorophenyl)-3-Quinolyl]-3,5-Dihydroxy-6-Heptenoic Acid, Pitavastatinum 
A novel statin that induces plaque regression and elevates HDL-cholesterol levels.

Topic mentions per year

Topic mentions per year

2000-2018
020406020002018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
OBJECTIVES The objective of this study was to evaluate whether the regressive effects of aggressive lipid-lowering therapy with… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
To investigate the contribution of genetic polymorphisms of SLCO1B1 and ABCG2 to the pharmacokinetics of a dual substrate… (More)
Is this relevant?
2007
2007
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors are known to modulate carcinogenesis. In this study, we… (More)
Is this relevant?
2007
2007
Recent studies have uncovered various pleiotrophic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase-inhibiting drugs… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
It has already been demonstrated that pitavastatin, a novel potent HMG-coenzyme A reductase inhibitor, is taken up into human… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Pitavastatin, a novel potent 3-hydroxymethylglutaryl coenzyme A reductase inhibitor, is distributed selectively to the liver and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Pitavastatin is a potent, newly developed 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor for the treatment… (More)
Is this relevant?
2005
2005
OBJECTIVE Liver-type fatty acid-binding protein (l-FABP) is expressed in renal proximal tubules and is reported to be a useful… (More)
  • table 1
  • table 2
  • table 4
  • table 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Pitavastatin, a novel potent 3-hydroxymethylglutaryl-CoA reductase inhibitor, is selectively distributed to the liver in rats… (More)
  • table 2
  • table 3
  • table 4
  • figure 1
  • figure 2
Is this relevant?
2001
2001
To clarify the mechanism of the stimulatory effect of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors… (More)
Is this relevant?